Clinicopathological features | Multivariate analysis* | Internal validation* | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age | 1.02 (1.02–1.03) | < 0.001 | 1.02 (1.02–1.03) | < 0.001 |
Tumor Location |  | < 0.001 |  | < 0.001 |
 Upper | Reference |  | Reference |  |
 Middle | 0.92 (0.72–1.17) |  | 0.91 (0.72–1.15) |  |
 Lower | 0.79 (0.64–0.97) |  | 0.78 (0.64–0.96) |  |
 Mixed | 1.32 (1.03–1.70) |  | 1.30 (1.02–1.66) |  |
Tumor size (cm) | 1.01 (1.00–1.01) | 0.003 | 1.01 (1.00–1.01) | < 0.001 |
pTNM stage |  | < 0.001 |  | < 0.001 |
 I | Reference |  | Reference |  |
 II | 2.00 (1.38–2.91) |  | 2.02 (1.42–2.88) |  |
 III | 6.81 (4.92–9.42) |  | 6.82 (4.97–9.36) |  |
CBCS |  | < 0.001 |  | < 0.001 |
 0 | Reference |  | Reference |  |
 1 | 1.29 (1.06–1.57) |  | 1.27 (1.03–1.54) |  |
 2 | 1.68 (1.35–2.09) |  | 1.60 (1.22–1.94) |  |